eno (Mindset Innovation II) Raises $700K Seed for Brain-Sensing Headphones

eno Closes $700K Seed Round

Mindset Innovation II, Inc., doing business as eno, has raised a $700,000 Seed round in USD, dated October 8, 2026. The Los Angeles-based neurotechnology company is building brain-sensing headphones that adapt audio in real time to the mental state of the listener.

No lead investor was disclosed for the round, and no participating investors were named.

What eno Builds

The company's flagship product, Enophone, pairs EEG sensors with companion iOS and Android apps to deliver closed-loop, adaptive soundscapes. The product is aimed at focus, calm, and better sleep, and is positioned as a general-wellness product rather than a medical device.

That positioning matters for how the company is likely to be evaluated. By staying outside the medical-device lane, eno avoids the regulatory pathway associated with clinical claims, while still collecting a biosignal — EEG — that has traditionally been confined to research and clinical settings. The closed-loop framing means the audio output is not static: it responds to the listener's measured mental state rather than playing a fixed track.

Company Background

eno is led by co-founder and CEO Roy Burstin, who previously ran the digital media brand mitu. He built eno through Moonshot LA, his Los Angeles venture studio.

The venture-studio origin is a notable structural detail. Studio-built companies typically begin with a founder and an operating thesis in place before outside capital arrives, which can compress the early product and team-building phase. In eno's case, the studio connection also ties the company to a specific Los Angeles operating base rather than a distributed or Bay Area footprint.

Round Summary

• Company: Mindset Innovation II, Inc. (dba eno)
• Round type: Seed
• Amount: $700,000 USD
• Date: October 8, 2026
• Lead investor: Not disclosed
• Named investors: None disclosed
• Stage: Seed
• Headquarters: Los Angeles, California
• Product: Enophone brain-sensing headphones with iOS and Android companion apps

Why It Matters

Consumer neurotechnology sits at an interesting intersection: the hardware is a wearable audio device, but the underlying capability is continuous biosignal capture. Companies in this space typically face two distinct challenges — building a sensor package that is comfortable and reliable enough for daily wear, and turning the resulting signal into an experience that a general consumer will keep using without a clinical rationale.

eno's answer to the second challenge is the closed-loop soundscape: the value proposition is not the data itself but the adaptive audio it drives. Focus, calm, and sleep are three of the most common consumer wellness use cases, which gives the product a broad addressable audience but also places it in a crowded category of audio and wellness hardware.

The $700,000 Seed is a modest round by current standards, consistent with an early-stage company that has shipped a flagship product and is now funding the next phase of development. With no lead investor disclosed, the round appears to have been assembled without a single anchoring institutional check.

What to Watch

For anyone tracking eno — as a potential partner, acquirer, or follow-on investor — the key questions are the ones the funding data does not answer: how many Enophone units are in market, what the retention curve looks like for the companion apps, and whether the general-wellness positioning holds as the company scales.

The company's Los Angeles base and studio lineage give it access to a specific local network of operators and media talent, which may prove relevant as it builds out consumer brand and distribution.